home / stock / rvmd / rvmd articles

RVMD Articles, Revolution Medicines Inc. - From 10/23/23

Stock Information
Company Name: Revolution Medicines Inc.
Stock Symbol: RVMD
Market: NASDAQ
Website: revmed.com
Menu
RVMD RVMD Quote RVMD Short RVMD News RVMD Articles RVMD Message Board
Get RVMD Alerts

News, Short Squeeze, Breakout and More Instantly...
FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday | Benzinga

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in toda...
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September | Benzinga

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow tra...

Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236 | Benzinga

REDWOOD CITY, Calif., Oct. 22, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing t...

Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday | Benzinga

U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s ses...
Why Is Cancer Focused Revolution Medicines Stock Trading Higher Today? | Benzinga

Revolution Medicines Inc (NASDAQ: RVMD) released preliminary data for RMC-6236, its RASMULTI(ON) Inhibitor, and RMC-6291, its RASG12C(ON) Inhi...

Revolution Medicines Presents Encouraging Clinical Data for RMC-6236 and RMC-6291 at 2023 Triple Meeting | Benzinga

 Clinical dose escalation data for RMC-6236, a RASMULTI(ON) Inhibitor, show oral bioavailability, well-tolerated safety profile and preliminary e...

Top 4 Health Care Stocks That Are Preparing To Pump This Quarter | Benzinga

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast | Benzinga

Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following...

Previous 10 Next 10